0001012975-26-000329.txt : 20260406 0001012975-26-000329.hdr.sgml : 20260406 20260406165040 ACCESSION NUMBER: 0001012975-26-000329 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260406 DATE AS OF CHANGE: 20260406 EFFECTIVENESS DATE: 20260406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avego BioScience Capital Fund II, L.P. CENTRAL INDEX KEY: 0002118686 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-579231 FILM NUMBER: 26841880 BUSINESS ADDRESS: STREET 1: 100 NORTH MAIN STREET, SUITE 301 CITY: ALPHARETTA STATE: GA ZIP: 30009 BUSINESS PHONE: 404-784-2900 MAIL ADDRESS: STREET 1: 100 NORTH MAIN STREET, SUITE 301 CITY: ALPHARETTA STATE: GA ZIP: 30009 D 1 primary_doc.xml X0708 D LIVE 0002118686 Avego BioScience Capital Fund II, L.P. 100 NORTH MAIN STREET, SUITE 301 ALPHARETTA GA GEORGIA 30009 (646) 844-1680 DELAWARE None None Limited Partnership true 2026 N/A Avego BioScience Capital GP II, LLC 100 North Main Street, Suite 301 Alpharetta GA GEORGIA 30009 Director The general partner of the Issuer (the "General Partner") Balaji Venkataraman c/o Avego Management, LLC 100 North Main Street, Suite 301 Alpharetta GA GEORGIA 30009 Executive Officer Managing Member of the General Partner Alyssa Romano c/o Avego Management, LLC One Penn Plaza, Suite 1620 New York NY NEW YORK 10119 Executive Officer Chief Compliance Officer of the General Partner Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 false 2026-04-01 true true false 0 BHA Select Network, LLC 168883 None None 1 Lincoln St., 29th floor Boston MA MASSACHUSETTS 02111 All States false Indefinite 60000000 Indefinite false 1 0 true 0 true The entity in Item 12 will receive a fee for certain investors investing in the Issuer in an amount equal to a percentage of such investors' commitments to the Issuer. 0 true An affiliate of the General Partner of the Issuer will receive a fee for management services, calculated in accordance with the Issuer's governing agreement. false Avego BioScience Capital Fund II, L.P. /s/ Balaji Venkataraman Balaji Venkataraman Manager of the General Partner 2026-04-06